Skip to content
Ask
← Canadian charities

Quebec · Registered charity

CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)

CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) (Quebec) receives grants from 10 organizations whose Canada Revenue Agency filings report C$64,911 to it, the largest being FONDS DE CHARITE DE LA 3E ESCADRE BAGOTVILLE (C$22,000). 7 of them have funded it in more than one year.

C$472k
Revenue FY2024
10
Funders on record
C$65k
Grants received
C$42k
Net assets
7/10 repeat funderspeak grant-dependency 3%

Against its field

CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)'s revenue grew 25% between 2017 and 2024.

Operating margin2% · below the median
Revenue growth (annualized)3% · below the median

this organization peer median middle 50% of peers· 947 core health care nonprofits $100k–$1M, FY2024

Three funders worth looking at

Grantmakers with no record of funding this organization, ranked by how strongly the co-funder graph and the mission embeddings agree. The evidence is in section 03.

See all 12 prospects and why each one surfaced →
01The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 (C$378k) Expenses 100 (C$389k) Net assets 100 (C$69k)2018 Revenue 92 (C$349k) Expenses 95 (C$371k) Net assets 69 (C$47k)2019 Revenue 103 (C$391k) Expenses 100 (C$389k) Net assets 72 (C$49k)2020 Revenue 88 (C$331k) Expenses 68 (C$264k) Net assets 170 (C$117k)2021 Revenue 94 (C$356k) Expenses 93 (C$362k) Net assets 162 (C$111k)2022 Revenue 101 (C$384k) Expenses 112 (C$435k) Net assets 88 (C$60k)2023 Revenue 116 (C$440k) Expenses 121 (C$470k) Net assets 45 (C$31k)2024 Revenue 125 (C$472k) Expenses 118 (C$461k) Net assets 62 (C$42k)
'17'18'19'20'21'22'23'24
Revenue (125)Expenses (118)Net assets (62)Peer revenue range

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2017 23% · 2018 22% · 2019 21% · 2020 42% · 2021 42% · 2022 24% · 2023 22% · 2024 21%. Grants only. Government contracts and fees sit inside program revenue.

71% of CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)’s revenue is contributions — more reliant on donations than three-quarters of its peers (21% for the typical peer).

This organization
Typical peer · 905 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.

−C$11k
’17
−C$21k
’18
C$2k
’19
C$67k
’20
−C$6k
’21
−C$51k
’22
−C$29k
’23
C$11k
’24
0.5
months of
reserve
02Who funds it

Who funds it, year by year

2018 → 2023: the base held at 4 funders, grant income fell C$8k → C$7k.

Funder
'18
'19
'20
'21
'22
'23
'24*
total
Canadahelps Canadonunclassified
C$965
funders
4
4
4
4
2
4
4

From the CRA filings of CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

How concentrated its funding is

CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) leans on a few funders — its largest provides 34% of grant income and the top three 81%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH).

34%
largest funder
81%
top three
~4
effective funders

Largest funder’s share by year: 2018 61% · 2019 70% · 2020 52% · 2021 70% · 2022 99% · 2023 71% — growing more concentrated.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

How long its funders stay

29% of CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)'s funders are still giving 3 years after their first grant; 70% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

71% of CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)'s grant income comes from Quebec funders.

In-province vs out-of-province, by year

’18
’19
’20
’21
’22
’23
Quebec out of province

Funder regions come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024 is still being filed and is shown unshaded; it does not move any figure on this page.

03Its place in the field

Funders to approach

Grantmakers that don’t fund you yet, surfaced two ways: they back organizations that share your funders, or their grantees resemble your mission. The ones both signals agree on come first. Your 10 funders put you under-funded among the 400 organizations that share them.

From the co-funder graph (funders backing at least two comparable organizations, shrunk for grantee count, donor-advised and mega-funds excluded) and the universe embeddings. A research starting point; overlap is association, not a guarantee of fit.

Government revenue CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) reports

Federal, provincial and municipal funding on the organization’s own T3010 return.

FY2024C$99k
17
18
19
20
21
22
23
24
  • 21% of FY2024 revenue
  • As filed, not traced to an award

Organizations like CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)

Organizations whose mission and program text most resemble this one, by semantic similarity over every charity on the CRA register — the closest peers, and often the clearest route to shared or prospective funders.

In Quebec

Centre Associatif Polyvalent D'Aide Hepatite C (Capahc)72%Societe Canadienne de L'Hemophilie Section Du Quebec71%Association de la Fibromyalgie Région Ile-De-Montreal70%Intitut Cardinal Léger Pour la Sante/Cardinal Léger Institute for Health70%Fondation Maison Colombe-Veilleux70%Centre Emilie Gamelin69%MISSION Corail-Haiti Québec Inc.69%La Maison de Kamu69%

Nationally

Centre Associatif Polyvalent D'Aide Hepatite C (Capahc)72%Societe Canadienne de L'Hemophilie Section Du Quebec71%Association de la Fibromyalgie Région Ile-De-Montreal70%Canadian Organization for Rare Disorders (Cord)70%Intitut Cardinal Léger Pour la Sante/Cardinal Léger Institute for Health70%Fondation Maison Colombe-Veilleux70%Centre Emilie Gamelin69%MISSION Corail-Haiti Québec Inc.69%
04Profile & governance

Read directly from this organization’s own T3010 return, as neutral context.

Where the money goes

45% of spending goes to programs.

Program 45%Management 22%Fundraising 34%

Governance

8
board members

Questions and answers

Who funds CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)?
CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) (Quebec) receives grants from 10 organizations whose Canada Revenue Agency filings report C$64,911 to it, the largest being FONDS DE CHARITE DE LA 3E ESCADRE BAGOTVILLE (C$22,000). 7 of them have funded it in more than one year.
How many funders does CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) have?
Canada Revenue Agency filings report 10 organizations giving C$64,911 in grants to CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH), 7 of which have funded it in more than one year.
Who is the largest funder of CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH)?
FONDS DE CHARITE DE LA 3E ESCADRE BAGOTVILLE is the largest funder on record, with C$22,000 in grants. The full list of funders is on this page.
How can an organization like CORPORATION DE RECHERCHE ET D'ACTION SUR LES MALADIES HEREDITAIRES (CORAMH) find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Quebec.

Play a game about who funds Corporation de Recherche Et D'Action Sur Les Maladies Hereditaires (Coramh) →

These figures are read directly from the CRA's published T3010 data: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 10 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported September 23, 2026. What this page cannot tell you · View the T3010 on the CRA register